Sanmina Corp. Hits Day Low of $123.64 Amid Price Pressure

Sanmina Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 10.27% as of October 7, 2025. The stock reached an intraday low of USD 123.64, marking a notable point in its trading activity. Despite this day's downturn, Sanmina Corp. has shown resilience over the past year, boasting an impressive 86.99% increase in stock value compared to the S&P 500's 17.2% gain. The company's performance metrics reveal a strong market position, highlighted by a high return on equity (ROE) of 12.73% and a low debt-to-equity ratio, indicating sound financial health. In terms of cash flow, Sanmina reported its highest operating cash flow at USD 473.46 million, alongside a robust interest coverage ratio of 2,673.96. The stock's price-to-book ratio stands at 5.07, reflecting an attractive valuation relative to its peers. With institutional holdings at 100%, Sanmina Corp. continues to maintain a solid foundation in the market, despite today's fluctuations.